Johnson & Johnson stock in focus: Trump drug-price pact and fresh cancer data before Monday
New York, Jan 11, 2026, 10:45 EST — Market closed. Shares of Johnson & Johnson (JNJ.N) dipped 0.7% on Friday to $204.39 following the company’s announcement of a deal with the Trump administration to lower U.S. drug prices. In return, J&J secured exemptions from certain U.S. tariffs. The company said it will offer medicines at discounted rates via TrumpRx.gov and…